ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
ELITE PHARMACEUTICALS INC | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
ELITE PHARMACEUTICALS INC | 8-K: Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call Information
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Elite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024 ended June 30, 2023 and Provides Conference Call Information
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Current report
No Data